Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2862)
All Articles published online
|
Feb 7, 2005 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liang B, Wang S, Zhu XG, Yu YX, Cui ZR, Yu YZ. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J Gastroenterol 2005; 11(5): 623-628 [PMID: 15655810 DOI: 10.3748/wjg.v11.i5.623] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i5/623.htm |
| Number | Citing Articles |
| 1 |
Furuzan Kacar, Ibrahim Meteoğlu, Hadi Yasa, E. Levi. Helicobacter pylori-induced Changes in the Gastric Mucosa are Associated With Mitogen-activated Protein Kinase (MAPK) Activation. Applied Immunohistochemistry & Molecular Morphology 2007; 15(2): 224 doi: 10.1097/01.pai.0000209863.35828.dd
|
| 2 |
Feima Wu, Qiang Mo, Xiaoling Wan, Jialong Dan, Haibo Hu. NEAT1/hsa‐mir‐98‐5p/MAPK6 axis is involved in non–small‐cell lung cancer development. Journal of Cellular Biochemistry 2019; 120(3): 2836 doi: 10.1002/jcb.26442
|
| 3 |
Ki Yong Na, Youn Wha Kim, Yong-Koo Park. Mitogen-activated protein kinase pathway in osteosarcoma. Pathology 2012; 44(6): 540 doi: 10.1097/PAT.0b013e32835803bc
|
| 4 |
Anna Tesei, Carlo Leonetti, Gabriella Zupi, Marco Scarsella, Giovanni Brigliadori, Paola Ulivi, Francesco Fabbri, Chiara Arienti, Dino Amadori, Alessandro Passardi, Rosella Silvestrini, Wainer Zoli. Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models. Journal of Cellular and Molecular Medicine 2011; 15(2): 316 doi: 10.1111/j.1582-4934.2009.00993.x
|
| 5 |
Mei Yang, Yu-yu Gu, Hua Peng, Mei Zhao, Jia Wang, Sheng-kai Huang, Xing-hua Yuan, Jia Li, Jian-li Sang, Qing Luo, Changzhi Huang. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways. Journal of Cancer Research and Clinical Oncology 2015; 141(6): 1037 doi: 10.1007/s00432-014-1865-2
|
| 6 |
Ralph Pries, Stefan Nitsch, Barbara Wollenberg. Role of cytokines in head and neck squamous cell carcinoma. Expert Review of Anticancer Therapy 2006; 6(9): 1195 doi: 10.1586/14737140.6.9.1195
|
| 7 |
Hazel Tye, Catherine L. Kennedy, Meri Najdovska, Louise McLeod, William McCormack, Norman Hughes, Anouk Dev, William Sievert, Chia Huey Ooi, Tomo-o Ishikawa, Hiroko Oshima, Prithi S. Bhathal, Andrew E. Parker, Masanobu Oshima, Patrick Tan, Brendan J. Jenkins. STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation. Cancer Cell 2012; 22(4): 466 doi: 10.1016/j.ccr.2012.08.010
|
| 8 |
Keiko Matsuura, Yuka Nohno, Naoki Hijiya, Tomohisa Uchida, Yoshiyuki Tsukamoto, Masatsugu Moriyama. Extracellular signal‐regulated protein kinase is activated in cervical intraepithelial neoplasms but inactivated in invasive cervical carcinoma. Pathology International 2006; 56(7): 368 doi: 10.1111/j.1440-1827.2006.01973.x
|
| 9 |
Hadel Alsaran, Lobna Elkhadragy, Astha Shakya, Weiwen Long. L290P/V mutations increase ERK3’s cytoplasmic localization and migration/invasion-promoting capability in cancer cells. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15135-9
|
| 10 |
Ujjawal Sharma, Deeksha Pal, Rajendra Prasad. A novel role of alkaline phosphatase in the ERK1/2 dephosphorylation in renal cell carcinoma cell lines: A new plausible therapeutic target. Biochimie 2014; 107: 406 doi: 10.1016/j.biochi.2014.09.016
|
| 11 |
Xiaojing Zhang, Yin Peng, Zhe Jin, Weiling Huang, Yulan Cheng, Yudan Liu, Xianling Feng, Mengting Yang, Yong Huang, Zhenfu Zhao, Liang Wang, Yanjie Wei, Xinmin Fan, Duo Zheng, Stephen J. Meltzer. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma. Oncotarget 2015; 6(32): 32878 doi: 10.18632/oncotarget.5419
|
| 12 |
Motoko Seto, Miki Ohta, Yoshinari Asaoka, Tsuneo Ikenoue, Motohisa Tada, Koji Miyabayashi, Dai Mohri, Yasuo Tanaka, Hideaki Ijichi, Keisuke Tateishi, Fumihiko Kanai, Takao Kawabe, Masao Omata. Regulation of the hedgehog signaling by the mitogen‐activated protein kinase cascade in gastric cancer. Molecular Carcinogenesis 2009; 48(8): 703 doi: 10.1002/mc.20516
|
| 13 |
Eid S. Alshammari, Amjad A. Aljagthmi, Andrew J. Stacy, Mike Bottomley, H. Nicholas Shamma, Madhavi P. Kadakia, Weiwen Long. ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07866-w
|
| 14 |
Jie Zhou, Qing Chen. Poor expression of microRNA‐135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1‐mediated MAPK signaling pathway. The FASEB Journal 2019; 33(3): 3420 doi: 10.1096/fj.201800618RRR
|
| 15 |
Pengwei Lv, Xinguang Qiu, Yuanting Gu, Xue Yang, Xiaodong Xu, Yunqing Yang. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer. Biomedicine & Pharmacotherapy 2019; 110: 294 doi: 10.1016/j.biopha.2018.11.016
|
| 16 |
Jialing Zhong, Mei Zhao, Qing Luo, Yiming Ma, Jian Liu, Jia Wang, Mei Yang, Xinghua Yuan, Jianli Sang, Changzhi Huang. CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway. Molecular and Cellular Biochemistry 2013; 372(1-2): 1 doi: 10.1007/s11010-012-1418-4
|
| 17 |
Liping Chen, Yuqin Pan, Ling Gu, Zhenlin Nie, Bangshun He, Guoqi Song, Rui Li, Yeqiong Xu, Tianyi Gao, Shukui Wang. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion. Experimental Biology and Medicine 2013; 238(8): 903 doi: 10.1177/1535370213493706
|
| 18 |
Lobna Elkhadragy, Hadel Alsaran, Marion Morel, Weiwen Long. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness. Journal of Biological Chemistry 2018; 293(42): 16193 doi: 10.1074/jbc.RA118.003699
|
| 19 |
Yan Shi, Huihui Sun. <p>Down-regulation of lncRNA LINC00152 Suppresses Gastric Cancer Cell Migration and Invasion Through Inhibition of the ERK/MAPK Signaling Pathway</p>. OncoTargets and Therapy 2020; : 2115 doi: 10.2147/OTT.S217452
|
| 20 |
Reena Thakur, Chander Raman Suri, Indu Pal Kaur, Praveen Rishi. Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges. Critical Reviews™ in Therapeutic Drug Carrier Systems 2023; 40(1): 49 doi: 10.1615/CritRevTherDrugCarrierSyst.2022040322
|
| 21 |
Vishal Sahu, Anant Mohan, Sharmistha Dey. p38 MAP kinases: plausible diagnostic and prognostic serum protein marker of non small cell lung cancer. Experimental and Molecular Pathology 2019; 107: 118 doi: 10.1016/j.yexmp.2019.01.009
|
| 22 |
Hyun-Jung An, Cheol-Jung Lee, Ga-Eun Lee, Youngwon Choi, Dohyun Jeung, Weidong Chen, Hye Suk Lee, Han Chang Kang, Joo Young Lee, Dae Joon Kim, Jin-Sung Choi, Eun Suh Cho, Jong-Soon Choi, Yong-Yeon Cho. FBXW7-mediated ERK3 degradation regulates the proliferation of lung cancer cells. Experimental & Molecular Medicine 2022; 54(1): 35 doi: 10.1038/s12276-021-00721-9
|
| 23 |
Yoshitaka Fujimori, Mikito Inokuchi, Yoko Takagi, Keiji Kato, Kazuyuki Kojima, Kenichi Sugihara. Prognostic value of RKIP and p-ERK in gastric cancer. Journal of Experimental & Clinical Cancer Research 2012; 31(1) doi: 10.1186/1756-9966-31-30
|
| 24 |
Min Kyung Jung, Youn Kyung Houh, Soogyeong Ha, Yoolhee Yang, Daejin Kim, Tae Sung Kim, Suk Ran Yoon, Sa Ik Bang, Byung Joo Cho, Wang Jae Lee, Hyunjeong Park, Daeho Cho. Recombinant Erdr1 suppresses the migration and invasion ability of human gastric cancer cells, SNU-216, through the JNK pathway. Immunology Letters 2013; 150(1-2): 145 doi: 10.1016/j.imlet.2013.01.012
|
| 25 |
Kjersti Jørgensen, Ben Davidson, Viví Ann Flørenes. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma. Modern Pathology 2006; 19(11): 1446 doi: 10.1038/modpathol.3800662
|
| 26 |
BeiLi Zhang, Yan Gu. Bortezomib inhibits gastric carcinoma HGC-27 cells through the phospho-Jun N-terminal kinase (p-JNK) pathway in vitro. Gene 2015; 559(2): 164 doi: 10.1016/j.gene.2015.01.035
|
| 27 |
Sirjana Shrestha, Sheng‐Da Hsu, Wei‐Yun Huang, Hsi‐Yuan Huang, WenLiang Chen, Shun‐Long Weng, Hsien‐Da Huang. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Medicine 2014; 3(4): 878 doi: 10.1002/cam4.246
|
| 28 |
Jaishree Pandian, Kumaresan Ganesan. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics. Experimental Cell Research 2022; 410(1): 112956 doi: 10.1016/j.yexcr.2021.112956
|
| 29 |
Wenguang Sun, Qi Wang, Bingqing Chen, Jiaren Liu, Huikun Liu, Weili Xu. γ-Tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling. British Journal of Nutrition 2008; 99(6): 1247 doi: 10.1017/S0007114507879128
|
| 30 |
Zhenwei Zhang, Lei Miao, Xiaoming Xin, Jianpeng Zhang, Shengsheng Yang, Mingyong Miao, Xiangping Kong, Binghua Jiao. Underexpressed CNDP2 Participates in Gastric Cancer Growth Inhibition through Activating the MAPK Signaling Pathway. Molecular Medicine 2014; 20(1): 17 doi: 10.2119/molmed.2013.00102
|
| 31 |
Minyi Chen, Amanda K. Myers, Michael P. Markey, Weiwen Long. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness. Journal of Cellular Physiology 2019; 234(8): 13220 doi: 10.1002/jcp.27994
|
| 32 |
Kamaldeep Gill, Lokesh Nigam, Ratnakar Singh, Suresh Kumar, Naidu Subbarao, Shyam Singh Chauhan, Sharmistha Dey, Ahmad Waseem. The Rational Design of Specific Peptide Inhibitor against p38α MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC. PLoS ONE 2014; 9(7): e101525 doi: 10.1371/journal.pone.0101525
|
| 33 |
Jihye Kim, Cherlhyun Kim, Tae Sung Kim, Sa Ik Bang, Young Yang, Hyunjeong Park, Daeho Cho. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochemical and Biophysical Research Communications 2006; 344(4): 1284 doi: 10.1016/j.bbrc.2006.04.016
|
| 34 |
Lobna Elkhadragy, Minyi Chen, Kennon Miller, Muh‐Hwa Yang, Weiwen Long. A regulatory BMI1/let‐7i/ERK3 pathway controls the motility of head and neck cancer cells. Molecular Oncology 2017; 11(2): 194 doi: 10.1002/1878-0261.12021
|
| 35 |
Yanni Ma, Qi Qi, Qingping He, Nailya S. Gilyazova, Gordon Ibeanu, P. Andy Li. Neuroprotection by B355252 against Glutamate-Induced Cytotoxicity in Murine Hippocampal HT-22 Cells Is Associated with Activation of ERK3 Signaling Pathway. Biological and Pharmaceutical Bulletin 2021; 44(11): 1662 doi: 10.1248/bpb.b21-00158
|
| 36 |
Hee Man Kim, Sun A Kim, Soo Been Park, Jae Hee Cho, Si Young Song. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth. Scandinavian Journal of Gastroenterology 2017; 52(5): 577 doi: 10.1080/00365521.2017.1278786
|
| 37 |
Susan Marqus, Elena Pirogova, Terrence J. Piva. Evaluation of the use of therapeutic peptides for cancer treatment. Journal of Biomedical Science 2017; 24(1) doi: 10.1186/s12929-017-0328-x
|
| 38 |
Yuan Zhou, Myew-Ling Toh, Saloua Zrioual, Pierre Miossec. IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells. Cytokine 2007; 38(3): 157 doi: 10.1016/j.cyto.2007.06.002
|
| 39 |
Weiwen Long, Charles E. Foulds, Jun Qin, Jian Liu, Chen Ding, David M. Lonard, Luisa M. Solis, Ignacio I. Wistuba, Jun Qin, Sophia Y. Tsai, Ming-Jer Tsai, Bert W. O’Malley. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. Journal of Clinical Investigation 2012; 122(5): 1869 doi: 10.1172/JCI61492
|
| 40 |
Taicheng Zhou, Zhihua Cai, Ning Ma, Wenzhuan Xie, Chan Gao, Mengli Huang, Yuezong Bai, Yangpeng Ni, Yunqiang Tang. A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00629
|
| 41 |
Tingting Zhao, Chun Wang, Xinying Huo, Ming‐Liang He, Jinfei Chen. Pterostilbene enhances sorafenib’s anticancer effects on gastric adenocarcinoma. Journal of Cellular and Molecular Medicine 2020; 24(21): 12525 doi: 10.1111/jcmm.15795
|
| 42 |
Daniele Maggioni, Renato Gaini, Gabriella Nicolini, Giovanni Tredici, Werner Garavello. MAPKs activation in head and neck squamous cell carcinomas. Oncology Reviews 2011; 5(4): 223 doi: 10.1007/s12156-011-0086-z
|
| 43 |
Takeo Fujita, Hiroyoshi Doihara, Kazuhiro Washio, Hideo Ino, Masakazu Murakami, Minoru Naito, Nobuyoshi Shimizu. Antitumor effects and drug interactions of the proteasome inhibitor bortezomib (PS341) in gastric cancer cells. Anti-Cancer Drugs 2007; 18(6): 677 doi: 10.1097/CAD.0b013e32808bf9d8
|
| 44 |
Jayaprakash Periasamy, Muthulakshmi Muthuswami, Divya Bhaskar Rao, Patrick Tan, Kumaresan Ganesan. Stratification and delineation of gastric cancer signaling by in vitro transcription factor activity profiling and integrative genomics. Cellular Signalling 2014; 26(5): 880 doi: 10.1016/j.cellsig.2014.01.017
|
| 45 |
M. Martin-Richard, R. Gallego, C. Pericay, J. Garcia Foncillas, B. Queralt, E. Casado, J. Barriuso, V. Iranzo, I. Juez, L. Visa, E. Saigi, A. Barnadas, X. Garcia-Albeniz, J. Maurel. Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study. Investigational New Drugs 2013; 31(6): 1573 doi: 10.1007/s10637-013-0020-2
|
| 46 |
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
|
| 47 |
Lobna Elkhadragy, Amanda Myers, Weiwen Long. Role of the Atypical MAPK ERK3 in Cancer Growth and Progression. Cancers 2024; 16(7): 1381 doi: 10.3390/cancers16071381
|
| 48 |
Christiane Klec, Felix Prinz, Martin Pichler. Involvement of the long noncoding RNA NEAT1 in carcinogenesis. Molecular Oncology 2019; 13(1): 46 doi: 10.1002/1878-0261.12404
|
| 49 |
P38 mitogen-activated protein kinase (p38 MAPK) overexpression in clinical staging of nasopharyngeal carcinoma. IOP Conference Series: Earth and Environmental Science 2018; 125: 012129 doi: 10.1088/1755-1315/125/1/012129
|
| 50 |
Javier Maldonado, Waldo Acevedo, Aurora Molinari, Alfonso Oliva, Marcela Knox, Arturo San Feliciano. Synthesis, in vitro evaluation and molecular docking studies of novel naphthoisoxazolequinone carboxamide hybrids as potential antitumor agents. Polycyclic Aromatic Compounds 2023; 43(6): 4960 doi: 10.1080/10406638.2022.2095410
|
| 51 |
J. Xu, M. M. Zhang, Q. Zhou, W. Liu. Xingnaojing Combined with Brain Glycoside Peptide Targets LncRNA-H19 and Regulates hsa-microRNA (miR)-138-5p/MAPK6 to Alleviate Acute Ischemic Stroke. Neurochemical Journal 2023; 17(3): 492 doi: 10.1134/S1819712423030182
|
| 52 |
Jian-xian Lin, Changhwan Yoon, Ping Li, Qian Yu, Sheng-liang Qiu, Chao-hui Zheng, Sam S. Yoon, Chang-Ming Huang. Increased CD44 Expression and MEK Activity Predict Worse Prognosis in Gastric Adenocarcinoma Patients Undergoing Gastrectomy. Journal of Gastrointestinal Surgery 2021; 25(5): 1147 doi: 10.1007/s11605-020-04616-4
|
| 53 |
Chika Takahashi, Koichi Miyatake, Morioh Kusakabe, Eisuke Nishida. The atypical mitogen-activated protein kinase ERK3 is essential for establishment of epithelial architecture. Journal of Biological Chemistry 2018; 293(22): 8342 doi: 10.1074/jbc.RA117.000992
|
| 54 |
Petra Hudler. Genetic Aspects of Gastric Cancer Instability. The Scientific World Journal 2012; 2012: 1 doi: 10.1100/2012/761909
|
| 55 |
Hyun‐Seuk Moon, Ding‐Ding Guo, Hong‐Gu Lee, Yun‐Jaie Choi, Jae‐Seong Kang, Kyungmin Jo, Jung‐Min Eom, Cheol‐Heui Yun, Chong‐Su Cho. Alpha‐eleostearic acid suppresses proliferation of MCF‐7 breast cancer cells via activation of PPARγ and inhibition of ERK 1 / 2. Cancer Science 2010; 101(2): 396 doi: 10.1111/j.1349-7006.2009.01389.x
|